MODERN APPROACHES TO THE TREATMENT OF DIABETIC RETINOPATHY
Keywords:
diabetic retinopathy, anti-VEGF therapy, laser photocoagulation, intravitreal corticosteroids, vitrectomy, vision preservation.Abstract
Diabetic retinopathy (DR) remains one of the leading causes of preventable vision loss and blindness among working-age adults worldwide. This review highlights current concepts in the pathogenesis, classification, and, most importantly, modern evidence-based therapeutic strategies for managing diabetic retinopathy, including systemic risk factor control, laser photocoagulation, intravitreal anti-VEGF agents, corticosteroid therapy, and vitrectomy. The article also discusses emerging technologies such as sustained-release drug implants and gene therapy prospects. Emphasis is placed on the importance of timely screening, multidisciplinary collaboration, and patient education to improve outcomes and preserve vision.
Downloads
References
1. Early Treatment Diabetic Retinopathy Study Research Group. (1985). Photocoagulation for diabetic macular edema. Arch Ophthalmol.
2. Diabetic Retinopathy Clinical Research Network (DRCR.net). (2015). Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema. N Engl J Med.
3. Cheung N., Mitchell P., Wong T.Y. (2010). Diabetic retinopathy. Lancet.
4. Brown D.M., Nguyen Q.D., Marcus D.M., et al. (2013). Long-term outcomes of ranibizumab therapy for diabetic macular edema. Ophthalmology.
5. Heier J.S., et al. (2016). Intravitreal aflibercept for diabetic macular edema: 100-week results. Ophthalmology.
